10-year pharmaceutical distribution agreement under which we distribute branded and generic pharmaceutical products to Walgreens pharmacies (US PVA)
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
10-year pharmaceutical distribution agreement under which we distribute branded and generic pharmaceutical products to Walgreens pharmacies (US PVA)
Generics purchasing services arrangement providing access to generics and related products through a global sourcing arrangement (WBAD Arrangement)
Board seat designated by WBA under the Shareholders Agreement; Ms. Barra served as a director until May 27, 2025
Acquisition of a majority of WBA's Alliance Healthcare businesses for cash plus two million shares of our Common Stock, subject to purchase price adjustments
Extension of the US PVA and the WBAD Arrangement by three years through 2029
Distribution agreement to supply branded and generic pharmaceutical products to WBA's Boots pharmacies in the United Kingdom
Loading...